GLP-1 weight-loss medications linked to improved cancer survival in certain patients​GLP-1 weight-loss medications linked to improved cancer survival in certain patients 

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of these popular similar diabetes and weight-loss medications. They found that the patients were much less likely to die within five years Read More

Study shows Ozempic could help dialysis patients qualify for kidney transplants​Study shows Ozempic could help dialysis patients qualify for kidney transplants 

Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney transplant. New research from Saint Louis University School of Medicine and SSM Health physicians reveals that breakthrough weight loss medications could change that—giving more patients a second chance at life. ​Obesity is one of the biggest barriers Read More

Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds​Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds 

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted by these drugs, boosting their effectiveness and enhancing anticancer immunotherapies.